NSE filing, NSE: QMSMEDI. Summary written from the filing by ALFA Finder's alert engine.
QMS Medical Allied Services Ltd: key numbers
- Share price
- ₹177.79
- Market cap
- ₹343.8 Cr
- Revenue (annual)
- ₹172.9 Cr
- Net profit (annual)
- ₹11.92 Cr
- P/E (TTM)
- 28.9×Sector 52.0×
- Promoter holding
- 68.11%+0.00% QoQ
- FII holding
- 0.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from QMS Medical Allied Services Ltd
All →QMS Medical Allied Services Annual General Meeting
QMS Medical Allied Services Limited held its 9th Annual General Meeting on September 30, 2026. Shareholders approved a 5% final dividend and adoption of financial results.
QMS Medical Allied Services Acquisition
QMS Medical Allied Services Limited is acquiring BeamOptics Scientific Private Limited. The strategic acquisition aims to expand the company's addressable market in healthcare business.
- Execution
- on or before 30th November, 2027
QMS Medical Allied Services Business Update
QMS Medical Allied Services executed a shareholders' agreement with investors and its subsidiary, Saarathi Healthcare, defining governance rights, veto powers, and share transfer restrictions.
QMS Medical Allied Services Merger & Restructuring
QMS Medical Allied Services Limited approved a composite demerger scheme for its healthcare business and the acquisition of a 100% stake in BeamOptics Scientific Private Limited.
QMS Medical Allied Services Acquisition Worth ₹14.22 Cr
QMS Medical Allied Services Ltd acquired the remaining 24% stake in Saarathi Healthcare Private Limited for Rs. 14.23 Crore, making it a wholly-owned subsidiary.
- Value
- ₹14.22 Cr
QMS Medical Allied Services Other Announcement
QMS Medical Allied Services Limited informed the exchange regarding the dispatch of annual report links to shareholders who haven't registered their email addresses.
Other board meeting date announcements
All →Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.
Parag Milk Foods Board Meeting Date
Parag Milk Foods has notified BSE of a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Trading window closure runs from 1 October to 5 November 2026.
Vedant Fashions Board Meeting Date
Vedant Fashions will hold a board meeting on 5 November 2026 to consider unaudited results for the quarter and half-year ended September 2026. The meeting is a prior intimation, so no results are approved yet.
Dangee Dums Board Meeting Date
Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.
Relic Technologies Board Meeting Date
Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.
EPL Board Meeting Date
EPL will hold a board meeting on November 4, 2026 to consider September quarter results. Trading window re-opens 48 hours after results are declared.